Rheumatoid Arthritis Likely Plays Causal Role in Inflammatory Bowel Disease
Researchers assessed whether rheumatoid arthritis is causally related to inflammatory bowel disease and vice versa.
Inflammatory Bowel Diseases (IBD)
Antibiotics and Older-Onset IBD: The Increased Risk in Adults Aged Over 60 Years
Adam S. Faye, MD, discusses his team’s research on how antibiotics increase the risk for inflammatory bowel disease among older adults and what clinicians should keep in mind.
No Improved Outcomes With Therapeutic Drug Monitoring in IBD Treatment
Researchers compared outcomes of therapeutic drug monitoring and conventional management in patients with inflammatory bowel disease receiving treatment with TNF-α antagonists.
Psychosocial Burden Common Among Patients With Inflammatory Bowel Disease
Researchers examined work productivity, disease severity, and patient-reported outcomes among individuals with inflammatory bowel disease.
Can Consuming Micronutrients Affect Ulcerative Colitis Risk?
Researchers examined the association between micronutrient intake and the risk for ulcerative colitis.
Diet-Induced Remission in Crohn Disease Linked to Metabolome Changes
Researchers examined changes in fecal metabolites resulting from either the Crohn disease exclusion diet plus enteral nutrition or the exclusive enteral nutrition diet and the association with remission.
Atopic Dermatitis Associated With Higher Risk for Autoimmune Disorders
Is autoimmune disease risk related to atopic dermatitis severity?
Upadacitinib Shows Potential for Treating Moderate to Severe Ulcerative Colitis
Researchers assessed the safety and efficacy of upadacitinib for use as induction and maintenance therapy in moderate to severe ulcerative colitis.
IPAA Surgery in Patients With Ulcerative Colitis, Obesity Linked to Adverse Outcomes
Researchers compared the outcomes of ileal pouch anal anastomosis construction in patients with vs without obesity who had ulcerative colitis.
AbbVie Seeks Crohn Disease Indication for Upadacitinib
The application is supported by data from the two phase 3 induction studies, U-EXCEED and U-EXCEL, and one phase 3 maintenance study, U-ENDURE.
- Loading...
Loading...
Next post in Crohn disease
Loading... 
Loading...